Improving the Effect of Multiple Sclerosis Drugs by Chronobiology
NCT06385197
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DEVICE:
App randomizing dosing regimen
Sponsor
Hadassah Medical Organization